Peking University People's Hospital Researchers Describe Research in Liver Cancer (Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen).

Keywords: Cancer; Carcinomas; Health and Medicine; Immunology; Liver Cancer; Oncology EN Cancer Carcinomas Health and Medicine Immunology Liver Cancer Oncology 608 608 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Investigators publish new report on liver cancer. In this study, we identified the potential neoantigens with tetramer staining, and established the Co-HA system, a single-plasmid system coexpressing patient human leukocyte antigen (HLA) and antigen, to detect the immunogenicity of neoantigens and verify new dominant hepatocellular carcinoma (HCC) neoantigens. [Extracted from the article]